共 342 条
[1]
Malhotra S(2016)Life-threatening ventricular arrhythmias: current role of imaging in diagnosis and risk assessment J Nucl Cardiol 23 1322-1334
[2]
Canty JM(2005)Regional 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction J Nucl Med 46 1368-1374
[3]
Luisi AJ(2002)Alterations of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart Eur J Nucl Med Mol Imaging 29 198-202
[4]
Suzuki G(2008)Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure J Nucl Med 49 234-241
[5]
Dekemp R(2015)The spectrum of epidemiology underlying sudden cardiac death Circ Res 116 1887-1906
[6]
Haka MS(1983)The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy J Nucl Med 24 672-682
[7]
Toorongian SA(2017)Current clinical applications and next steps for cardiac innervation imaging Curr Cardiol Rep 19 1-2221
[8]
Canty JM(2010)ChandnaH, Narula J, ADMIREHF Investigators. Myocardial iodine-123 metaiodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study J Am Coll Cardiol 55 2212-1018
[9]
Bengel FM(2015)123I-MIBG imaging for prediction of mortality and potentially fatal events in heart failure: the ADMIRE-HFX study J Nucl Med 56 1011-2301
[10]
Permanetter B(2017)What future for the myocardial sympathetic innervation imaging? Eur J Nucl Med Mol Imaging 44 2299-391